Results 11 to 20 of about 31,515 (266)

Shifting Paradigms in Antifungal Prophylaxis and Their Effects on Candidemia Outcomes in Hematological Malignancies: A 14-Year Experience from a Single Tertiary Center [PDF]

open access: yesJournal of Fungi
Evolving antifungal prophylaxis approaches have reshaped candidemia patterns and outcomes in hematological malignancy (HM) patients. This study aimed to evaluate temporal changes in candidemia incidence, species distribution, and factors associated with ...
Fazıl Çağrı Hunutlu   +11 more
doaj   +2 more sources

Antifungal prophylaxis with nebulized amphotericin-B in solid-organ transplant recipients with severe COVID-19: a retrospective observational study [PDF]

open access: yesFrontiers in Cellular and Infection Microbiology, 2023
COVID-19-associated pulmonary aspergillosis (CAPA) has emerged as a frequent complication in the intensive care unit (ICU). However, little is known about this life-threatening fungal superinfection in solid organ transplant recipients (SOTRs), including
Alexander Rombauts   +21 more
doaj   +2 more sources

Reply: Antifungal Prophylaxis. [PDF]

open access: yesAnn Am Thorac Soc, 2021
Pennington KM, Razonable RR, Kennedy CC.
europepmc   +4 more sources

Antifungal Prophylaxis and Treatment of Breakthrough Invasive Fungal Diseases in High-Risk Hematology Patients: A Prospective Observational Multicenter Study. [PDF]

open access: greenIndian J Hematol Blood Transfus
Metan G   +24 more
europepmc   +3 more sources

Real-World Outcomes of Antifungal Prophylaxis in Adult Acute Lymphoblastic Leukemia Patients: A Multicenter Comparison of the Use of Fluconazole and Micafungin. [PDF]

open access: goldJ Clin Med
Atas U   +26 more
europepmc   +2 more sources

Caspofungin for Primary Antifungal Prophylaxis in Acute Myeloid Leukemia: A Real-Life Study from an Academic Center. [PDF]

open access: goldCancers (Basel)
Grimaldi F   +14 more
europepmc   +3 more sources

Home - About - Disclaimer - Privacy